SETDB1 was recently found to be the most significantly up-regulated epigenetic regulator in human hepatocellular carcinomas, which also correlated with disease progression, cancer aggressiveness and poorer prognosis [160]. Here, SETDB1 is linked to hepatocellular carcinoma.